Hantz Financial Services’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Hold |
21
| – | – | ﹤0.01% | 2260 |
|
|
2025
Q1 | $0 | Hold |
21
| – | – | ﹤0.01% | 1882 |
|
|
2024
Q4 | $0 | Hold |
21
| – | – | ﹤0.01% | 1176 |
|
|
2024
Q3 | $0 | Hold |
21
| – | – | ﹤0.01% | 1150 |
|
|
2024
Q2 | $0 | Sell |
21
-101
| -83% | – | ﹤0.01% | 1197 |
|
|
2024
Q1 | $1K | Sell |
122
-19
| -13% | -$156 | ﹤0.01% | 1139 |
|
|
2023
Q4 | $1K | Sell |
141
-10,357
| -99% | -$73.5K | ﹤0.01% | 1084 |
|
|
2023
Q3 | $105K | Buy |
10,498
+758
| +8% | +$7.58K | ﹤0.01% | 589 |
|
|
2023
Q2 | $121K | Buy |
9,740
+74
| +0.8% | +$919 | ﹤0.01% | 567 |
|
|
2023
Q1 | $135K | Buy |
9,666
+1,398
| +17% | +$19.5K | ﹤0.01% | 560 |
|
|
2022
Q4 | $118K | Buy |
8,268
+432
| +6% | +$6.17K | ﹤0.01% | 565 |
|
|
2022
Q3 | $200K | Buy |
7,836
+589
| +8% | +$15K | 0.01% | 517 |
|
|
2022
Q2 | $206K | Buy |
7,247
+795
| +12% | +$22.6K | 0.01% | 510 |
|
|
2022
Q1 | $228K | Buy |
6,452
+1,340
| +26% | +$47.4K | 0.01% | 516 |
|
|
2021
Q4 | $214K | Buy |
5,112
+984
| +24% | +$41.2K | 0.01% | 504 |
|
|
2021
Q3 | $203K | Buy |
4,128
+869
| +27% | +$42.7K | 0.01% | 491 |
|
|
2021
Q2 | $136K | Buy |
3,259
+1,535
| +89% | +$64.1K | 0.01% | 495 |
|
|
2021
Q1 | $61K | Buy |
1,724
+636
| +58% | +$22.5K | ﹤0.01% | 516 |
|
|
2020
Q4 | $31K | Buy |
+1,088
| New | +$31K | ﹤0.01% | 508 |
|